Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have earned a consensus rating of “Hold” from the eighteen brokerages that are currently covering the stock, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $22.9286.

BBWI has been the subject of a number of recent research reports. Morgan Stanley reiterated an “equal weight” rating and set a $18.00 price target (down from $43.00) on shares of Bath & Body Works in a report on Friday, November 21st. UBS Group raised their target price on shares of Bath & Body Works from $17.00 to $21.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Guggenheim began coverage on shares of Bath & Body Works in a research note on Tuesday, December 9th. They issued a “neutral” rating for the company. Barclays increased their price target on Bath & Body Works from $18.00 to $20.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 6th. Finally, Robert W. Baird set a $20.00 price objective on Bath & Body Works in a report on Wednesday, December 17th.

Bath & Body Works Stock Up 5.3%

NYSE BBWI opened at $24.07 on Tuesday. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $41.87. The business has a fifty day moving average of $21.44 and a 200-day moving average of $24.01. The stock has a market cap of $4.93 billion, a price-to-earnings ratio of 7.41, a price-to-earnings-growth ratio of 1.06 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the business posted $0.49 EPS. The company’s revenue for the quarter was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. As a group, analysts anticipate that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 6th. Shareholders of record on Friday, February 20th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend is Friday, February 20th. Bath & Body Works’s dividend payout ratio (DPR) is presently 24.62%.

Insiders Place Their Bets

In related news, Director Stephen D. Steinour bought 6,700 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average cost of $14.86 per share, for a total transaction of $99,562.00. Following the completion of the acquisition, the director owned 48,175 shares in the company, valued at $715,880.50. This trade represents a 16.15% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Francis Hondal purchased 3,343 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average cost of $14.99 per share, with a total value of $50,111.57. Following the transaction, the director directly owned 21,554 shares of the company’s stock, valued at $323,094.46. The trade was a 18.36% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 33,513 shares of company stock worth $500,442 over the last 90 days. Corporate insiders own 0.27% of the company’s stock.

Institutional Trading of Bath & Body Works

Several institutional investors have recently made changes to their positions in BBWI. Parkside Financial Bank & Trust raised its position in shares of Bath & Body Works by 24.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock worth $55,000 after buying an additional 364 shares during the period. Gabelli Funds LLC grew its position in Bath & Body Works by 1.2% during the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock valued at $1,225,000 after acquiring an additional 542 shares during the period. Parallel Advisors LLC increased its stake in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Bath & Body Works by 3.7% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after purchasing an additional 600 shares during the period. Finally, Meeder Asset Management Inc. raised its holdings in shares of Bath & Body Works by 28.5% in the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after purchasing an additional 637 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Key Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Negative Sentiment: Multiple law firms have either filed or are soliciting plaintiffs in a securities class action against Bath & Body Works alleging violations of Sections 10(b) and 20(a) and Rule 10b‑5, covering purchases between June 4, 2024 and November 19, 2025; lead‑plaintiff deadlines are being advertised around March 13–16, 2026. These notices signal active litigation and potential future settlement or judgment exposure. DJS Law Group Notice Rosen Law Firm Notice Kessler Topaz Notice

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.